Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Deargen Annonuces Patent Application for a TNBC Target Novel Drug Candidate Using AI 2021-12-22 22:00
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy 2021-12-22 21:00
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines 2021-12-22 19:00
TCM provides new alternatives for the fight against COVID-19 2021-12-22 10:15
Jolly Good develops a medical VR filming system exclusively for ambulances with physicians 2021-12-21 21:00
Henlius' anti-PD-1 mAb MRCT achieved 15.38 months OS in first-line treatment of SCLC, reducing the risk of death by 38% of the overall population 2021-12-20 22:00
I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization 2021-12-20 21:00
First Patient Dosed in Australia in ATG-101 First-in-Human Trial 2021-12-20 10:56
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma 2021-12-17 20:00
Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia 2021-12-16 21:00
Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index 2021-12-16 21:00
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2021-12-16 21:00
Launching the world's first all-in-one medical and welfare VR platform JOLLYGOOD+ 2021-12-16 21:00
Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting 2021-12-16 20:00
Bionomics Limited Announces Pricing of Initial Public Offering in the United States 2021-12-16 19:00
Statement by WuXi AppTec Regarding Recent Market Fluctuation 2021-12-16 08:00
SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US 2021-12-15 22:00
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes 2021-12-15 21:01
I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China 2021-12-15 21:00
Red Seal brings New Zealand's #1 best-selling herbal and mineral toothpaste to Pharmaca Integrative Pharmacies, USA 2021-12-15 10:41
1 147 148 149 150 151 433